drugset / Trial / NCT00722956

Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin

NCT00722956

Phase 1 Completed 12 enrolled AstraZeneca
Non-randomizedSingle-groupOpen-labelBasic science

Summary

The purpose of the study is to assess the pharmacokinetics of both AZD5672 (steady-state) and atorvastatin (single dose) when co administered in healthy volunteers

Timeline

Start
2008-07
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD5672 Small molecule 100 mg
Subject Atorvastatin Small molecule 40 mg

Indications

No indication recorded.